Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franc Llorens

Showing results (101-110 of 120) with videos related to

Pageof 12
Sort By:
Nature Communications|February 1, 2020
Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementiaFranc Llorens, Peter Hermann, Anna Villar-Piqué, et al.
BMC Genomics|June 4, 2013
Microarray and deep sequencing cross-platform analysis of the mirRNome and isomiR variation in response to epidermal growth factorFranc Llorens, Manuela Hummel, Lorena Pantano, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 8, 2019
RNA editing alterations define manifestation of prion diseasesEirini Kanata, Franc Llorens, Dimitra Dafou, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 3, 2019
Prion protein quantification in human cerebrospinal fluid as a tool for prion disease drug developmentSonia M Vallabh, Chloe K Nobuhara, Franc Llorens, et al.
The Lancet. Neurology|February 20, 2021
Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob diseasePeter Hermann, Brian Appleby, Jean-Philippe Brandel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 22, 2016
Evaluation of α-synuclein as a novel cerebrospinal fluid biomarker in different forms of prion diseasesFranc Llorens, Niels Kruse, Matthias Schmitz, et al.
BMC Genomics|June 25, 2011
Multiple platform assessment of the EGF dependent transcriptome by microarray and deep tag sequencing analysisFranc Llorens, Manuela Hummel, Xavier Pastor, et al.
Molecular & Cellular Proteomics : MCP|September 28, 2019
Domain-specific Quantification of Prion Protein in Cerebrospinal Fluid by Targeted Mass SpectrometryEric Vallabh Minikel, Eric Kuhn, Alexandra R Cocco, et al.
Biomolecules|February 16, 2020
Diagnostic Accuracy of Prion Disease Biomarkers in Iatrogenic Creutzfeldt-Jakob DiseaseFranc Llorens, Anna Villar-Piqué, Peter Hermann, et al.
Molecular Neurobiology|May 8, 2015
Validation of 14-3-3 Protein as a Marker in Sporadic Creutzfeldt-Jakob Disease DiagnosticMatthias Schmitz, Elisabeth Ebert, Katharina Stoeck, et al.
Pageof 12

Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
Nature Communications|February 1, 2020
Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementiaFranc Llorens, Peter Hermann, Anna Villar-Piqué, et al.
BMC Genomics|June 4, 2013
Microarray and deep sequencing cross-platform analysis of the mirRNome and isomiR variation in response to epidermal growth factorFranc Llorens, Manuela Hummel, Lorena Pantano, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 8, 2019
RNA editing alterations define manifestation of prion diseasesEirini Kanata, Franc Llorens, Dimitra Dafou, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 3, 2019
Prion protein quantification in human cerebrospinal fluid as a tool for prion disease drug developmentSonia M Vallabh, Chloe K Nobuhara, Franc Llorens, et al.
The Lancet. Neurology|February 20, 2021
Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob diseasePeter Hermann, Brian Appleby, Jean-Philippe Brandel, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 22, 2016
Evaluation of α-synuclein as a novel cerebrospinal fluid biomarker in different forms of prion diseasesFranc Llorens, Niels Kruse, Matthias Schmitz, et al.
BMC Genomics|June 25, 2011
Multiple platform assessment of the EGF dependent transcriptome by microarray and deep tag sequencing analysisFranc Llorens, Manuela Hummel, Xavier Pastor, et al.
Molecular & Cellular Proteomics : MCP|September 28, 2019
Domain-specific Quantification of Prion Protein in Cerebrospinal Fluid by Targeted Mass SpectrometryEric Vallabh Minikel, Eric Kuhn, Alexandra R Cocco, et al.
Biomolecules|February 16, 2020
Diagnostic Accuracy of Prion Disease Biomarkers in Iatrogenic Creutzfeldt-Jakob DiseaseFranc Llorens, Anna Villar-Piqué, Peter Hermann, et al.
Molecular Neurobiology|May 8, 2015
Validation of 14-3-3 Protein as a Marker in Sporadic Creutzfeldt-Jakob Disease DiagnosticMatthias Schmitz, Elisabeth Ebert, Katharina Stoeck, et al.
Pageof 12